MYC and breast cancer: Given that c-MYC is overexpressed in approximately 70% of breast cancers, yet upstream miRNA-based regulation is poorly defined, we prioritized miR-32-5p to investigate its functional impact on this pivotal oncogene in MCF-7 cells.